Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15681532 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
Condition: Dermatofibrosarcoma
Intervention: Drug: Imatinib (Glivec)

Indicates status has not been verified in more than two years